HORMONE RECEPTOR POSITIVE BREAST NEOPLASMS

Clinical trials for HORMONE RECEPTOR POSITIVE BREAST NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new HORMONE RECEPTOR POSITIVE BREAST NEOPLASMS trials appear

Sign up with your email to follow new studies for HORMONE RECEPTOR POSITIVE BREAST NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Early cancer drug trial halted after safety testing

Disease control Terminated

This early-stage study aimed to test the safety and find the right dose of a new drug called Felmetatug Vedotin for people with advanced solid tumors. It was for adults with cancers like ovarian, breast, lung, and others that had spread or could not be removed by surgery. The tri…

Matched conditions: HORMONE RECEPTOR POSITIVE BREAST NEOPLASMS

Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

HORMONE RECEPTOR POSITIVE BREAST NEOPLASMS

Get alerted when new HORMONE RECEPTOR POSITIVE BREAST NEOPLASMS trials appear

Early cancer drug trial halted after safety testing